Galmed Pharmaceuticals Ltd. Stock News

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu

Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and...

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of Aramchol, a liver targeted, oral, SCD1 modulator, curre

BioCryst Pharmaceuticals (BCRX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Irhythm Technologies (IRTC), Madrigal Pharmaceuticals

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Theratechnologies (THTX), Intercept Pharma (ICPT) and

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Theratechnologies ( THTX – Research Report ), Intercept Pharma ( ICPT – Research Report ) and Xenco

Although the first wave (the companies with drugs at Phase-3) is already at the finish line, the effectiveness indicators of these drugs are far from being stro

Non-alcoholic steatohepatitis, or NASH, is a metabolic disorder caused by a buildup of fat in the liver, leading to liver inflammation and damage. It belongs to a group of conditions called non-alcoho

Gainers Myomo Inc (NYSE: MYO) shares climbed 114.7% to close at $12.99 on Tuesday after the company's MyoPro was approved for reimbursement by German health insurer BARMER....

Upgrades For Green Dot Corp (NYSE: GDOT), Citigroup upgraded the stock from Sell to Neutral. For the third quarter, Green Dot had an EPS of $0.20, compared to year...